Clinical trial

Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy

NCT07463092

Study summary

ClinicalTrials.gov

Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIETARY_SUPPLEMENT · Unmapped registry intervention Creatine Monohydrate Find medicine records · Find other trials using this name

DIETARY_SUPPLEMENT · Unmapped registry intervention Maltodextrin Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Resistance training Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-05-01

PhaseNA

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Sarcopeniaunresolved

Interventions

Creatine MonohydrateDIETARY_SUPPLEMENT

MaltodextrinDIETARY_SUPPLEMENT

Resistance trainingBEHAVIORAL

Sponsors & collaborators

University of Sao Paulolead sponsor

InCor Heart Institutecollaborator

Instituto do Cancer do Estado de São Paulocollaborator

Mapped research locations

São PauloSão Paulo, Brazil1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07463092 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.